LYELL IMMUNOPHARMA, INC.

Insiders Lyell Immunopharma, Inc.

Equities

LYEL

US55083R1041

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
2.54 ^USD	+5.83%		0.00%	+30.93%

05-06	Sector Update: Health Care Stocks Higher in Late Afternoon Trading	MT
05-06	Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Insider Sell: Lyell Immunopharma	17/08/23	MT
Lyell Immunopharma Names Chief Business Officer	05/07/23	MT
Lyell Immunopharma, Inc. Appoints Matthew Lang as Chief Business Officer	05/07/23	CI
Lyell Immunopharma, Inc. Announce Resignation of Rahsaan Thompson as the Chief Legal Officer	06/06/23	CI
Lyell Immunopharma Names Lynn Seely as Chief Executive	15/12/22	MT
Lyell Immunopharma, Inc. Appoints Lynn Seely as CEO	15/12/22	CI
Lyell Immunopharma, Inc. Appoints Lynn Seely as President	15/12/22	CI
Lyell Immunopharma Names Rahsaan W. Thompson Chief Legal Officer	28/09/22	MT
Lyell Immunopharma, Inc. Announces the Appointment of Rahsaan W. Thompson as Chief Legal Officer	28/09/22	CI
Lyell Immunopharma Names Gary Lee as Chief Scientific Officer	01/02/22	MT
Lyell Immunopharma Announces Executive Changes	31/01/22	CI
Lyell Immunopharma, Inc. Announces Richard Klausner Return from His Medical Leave to Continue as Chair of the Board	03/12/21	CI
Lyell Immunopharma Chairman Rick Klausner Emerges From Medical Leave	03/12/21	MT
Lyell Immunopharma, Inc. Announces Promotion of Stephen Hill to Chief Operating Officer	28/10/21	CI
Lyell Immunopharma, Inc. Announces Executive Changes	30/09/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer